PMC:7405836 / 121620-121887 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T73","span":{"begin":92,"end":96},"obj":"Body_part"},{"id":"T74","span":{"begin":156,"end":163},"obj":"Body_part"},{"id":"T75","span":{"begin":221,"end":225},"obj":"Body_part"}],"attributes":[{"id":"A73","pred":"fma_id","subj":"T73","obj":"http://purl.org/sig/ont/fma/fma68646"},{"id":"A74","pred":"fma_id","subj":"T74","obj":"http://purl.org/sig/ont/fma/fma67257"},{"id":"A75","pred":"fma_id","subj":"T75","obj":"http://purl.org/sig/ont/fma/fma68646"}],"text":"dings, we can confirm the significance of COVID-19 HR1 and HR2 and their vital role in host cell entry. Hence, fusion inhibitors target the HR1 domain of S protein, thereby preventing viral fusion and entry into the host cell. This is another potential therapeutic st"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T1069","span":{"begin":42,"end":50},"obj":"Disease"}],"attributes":[{"id":"A1069","pred":"mondo_id","subj":"T1069","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"dings, we can confirm the significance of COVID-19 HR1 and HR2 and their vital role in host cell entry. Hence, fusion inhibitors target the HR1 domain of S protein, thereby preventing viral fusion and entry into the host cell. This is another potential therapeutic st"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T175","span":{"begin":92,"end":96},"obj":"http://purl.obolibrary.org/obo/GO_0005623"},{"id":"T176","span":{"begin":221,"end":225},"obj":"http://purl.obolibrary.org/obo/GO_0005623"}],"text":"dings, we can confirm the significance of COVID-19 HR1 and HR2 and their vital role in host cell entry. Hence, fusion inhibitors target the HR1 domain of S protein, thereby preventing viral fusion and entry into the host cell. This is another potential therapeutic st"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T291","span":{"begin":118,"end":128},"obj":"Chemical"},{"id":"T292","span":{"begin":156,"end":163},"obj":"Chemical"}],"attributes":[{"id":"A291","pred":"chebi_id","subj":"T291","obj":"http://purl.obolibrary.org/obo/CHEBI_35222"},{"id":"A292","pred":"chebi_id","subj":"T292","obj":"http://purl.obolibrary.org/obo/CHEBI_36080"}],"text":"dings, we can confirm the significance of COVID-19 HR1 and HR2 and their vital role in host cell entry. Hence, fusion inhibitors target the HR1 domain of S protein, thereby preventing viral fusion and entry into the host cell. This is another potential therapeutic st"}

{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T34","span":{"begin":201,"end":225},"obj":"http://purl.obolibrary.org/obo/GO_0044409"}],"text":"dings, we can confirm the significance of COVID-19 HR1 and HR2 and their vital role in host cell entry. Hence, fusion inhibitors target the HR1 domain of S protein, thereby preventing viral fusion and entry into the host cell. This is another potential therapeutic st"}

{"project":"LitCovid-sentences","denotations":[{"id":"T821","span":{"begin":104,"end":226},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"dings, we can confirm the significance of COVID-19 HR1 and HR2 and their vital role in host cell entry. Hence, fusion inhibitors target the HR1 domain of S protein, thereby preventing viral fusion and entry into the host cell. This is another potential therapeutic st"}

{"project":"LitCovid-PubTator","denotations":[{"id":"3280","span":{"begin":154,"end":155},"obj":"Gene"},{"id":"3286","span":{"begin":42,"end":50},"obj":"Disease"}],"attributes":[{"id":"A3280","pred":"tao:has_database_id","subj":"3280","obj":"Gene:43740568"},{"id":"A3286","pred":"tao:has_database_id","subj":"3286","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"dings, we can confirm the significance of COVID-19 HR1 and HR2 and their vital role in host cell entry. Hence, fusion inhibitors target the HR1 domain of S protein, thereby preventing viral fusion and entry into the host cell. This is another potential therapeutic st"}